Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of the American College of Cardiology
|
March 5, 2020
Pathogenic FBN1 Genetic Variation and Aortic Dissection in Patients With Marfan Syndrome
Olivier Milleron, Florence Arnoult, Gabriel Delorme, et al.
Archives of Cardiovascular Diseases
|
July 13, 2010
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome
Delphine Detaint, Philippe Aegerter, Florence Tubach, et al.
Plos One
|
May 9, 2014
Early-onset osteoarthritis, Charcot-Marie-Tooth like neuropathy, autoimmune features, multiple arterial aneurysms and dissections: an unrecognized and life threatening condition
Mélodie Aubart, Delphine Gobert, Fleur Aubart-Cohen, et al.
European Heart Journal
|
May 4, 2015
Marfan Sartan: a randomized, double-blind, placebo-controlled trial
Olivier Milleron, Florence Arnoult, Jacques Ropers, et al.
Circulation
|
December 10, 2009
Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders
David Attias, Chantal Stheneur, Carine Roy, et al.
Nature Genetics
|
July 10, 2012
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome
Catherine Boileau, Dong-Chuan Guo, Nadine Hanna, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of the American College of Cardiology
|
March 5, 2020
Pathogenic FBN1 Genetic Variation and Aortic Dissection in Patients With Marfan Syndrome
Olivier Milleron, Florence Arnoult, Gabriel Delorme, et al.
Archives of Cardiovascular Diseases
|
July 13, 2010
Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome
Delphine Detaint, Philippe Aegerter, Florence Tubach, et al.
Plos One
|
May 9, 2014
Early-onset osteoarthritis, Charcot-Marie-Tooth like neuropathy, autoimmune features, multiple arterial aneurysms and dissections: an unrecognized and life threatening condition
Mélodie Aubart, Delphine Gobert, Fleur Aubart-Cohen, et al.
European Heart Journal
|
May 4, 2015
Marfan Sartan: a randomized, double-blind, placebo-controlled trial
Olivier Milleron, Florence Arnoult, Jacques Ropers, et al.
Circulation
|
December 10, 2009
Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders
David Attias, Chantal Stheneur, Carine Roy, et al.
Nature Genetics
|
July 10, 2012
TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome
Catherine Boileau, Dong-Chuan Guo, Nadine Hanna, et al.
Page
of 4